Form 10-KT/A - Transition reports [Rule 13a-10 or 15d-10]: [Amend]
SEC Accession No. 0001070698-13-000033
Filing Date
2013-06-19
Accepted
2013-06-19 16:05:41
Documents
5
Period of Report
2013-06-19

Document Format Files

Seq Description Document Type Size
1 RAPTOR PHARMACEUTICAL CORP AMENDED FORM 10-KT_12-31-2012 rptp_10kta1_12312012.htm 10-KT/A 80518
2 CERTIFICATION OF CEO rptp_exh311.htm EX-31.1 6583
3 CERTIFICATION OF CFO rptp_exh312.htm EX-31.2 6500
4 CERTIFICATION OF CEO AND CFO rptp_exh321.htm EX-32.1 6666
5 RAPTOR-HEALTHCARE ROYALTY PARTNERS LOAN AGREEMENT rptp_exb1038a.htm EX-10.38 1364200
  Complete submission text file 0001070698-13-000033.txt   1465784
Mailing Address 9 COMMERCIAL BLVD SUITE 200 NOVATO CA 94949
Business Address 9 COMMERCIAL BLVD SUITE 200 NOVATO CA 94949 415-382-1390
Raptor Pharmaceutical Corp (Filer) CIK: 0001070698 (see all company filings)

EIN.: 860883978 | State of Incorp.: DE | Fiscal Year End: 0831
Type: 10-KT/A | Act: 34 | File No.: 000-25571 | Film No.: 13922098
SIC: 2834 Pharmaceutical Preparations